75000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Unaudited Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Unaudited Condensed Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Unaudited Condensed Consolidated Statements of Shareholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Organization and Description of the Business link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Business Combinations and Contingent Consideration Liabilities link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Shareholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Collaborative Arrangement link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Business Combinations and Contingent Consideration Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Organization and Description of the Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Summary of Significant Accounting Policies - Schedule of Concentration of Risk (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Revenues Generated by Unaffiliated Customers (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Potential Common Shares (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Business Combinations and Contingent Consideration Liabilities - Schedule of Fair Value of Contingent Consideration Liability (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Business Combinations and Contingent Consideration Liabilities - Schedule of Contingent Consideration, Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Business Combinations and Contingent Consideration Liabilities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Property and Equipment, Net - Schedule of Right-of-use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Property and Equipment, Net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Intangible Assets, Net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments for Operating and Financing Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments for Operating and Financing Leases (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Operating and Financing Lease (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Shareholders' (Deficit) Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Stock-Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Collaborative Arrangement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Segment Reporting (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Segment Reporting - Schedule of Single Reportable Segment Profit or Loss information (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Segment Reporting - Schedule of Single Reportable Segment Profit or Loss information (Details) 3 link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Segment Reporting - Schedule of Revenues and Long-lived Assets by Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Weighted average exercise price,RSUs vested Weighted Average Grant Date Fair Value, RSUs and PSUs vested Chronix [Member] Chronix [Member] Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Loss before income taxes Loss before income taxes Concentration Risk Type [Axis] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Finance lease Total financing lease liabilities Present value of net minimum lease payments Finance lease, liability Entity Incorporation, State or Country Code Finance Lease, Liability, to be Paid, Year Four 2030 Preferred stock, shares issued Statement of Financial Position Location, Balance [Domain] Weighted average exercise price, options outstanding, exercisable Share based compensation arrangement by share based payment award option outstanding weighted average exercise price. ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice Total contributions to the plan Pharma Services Company A [Member] Pharma Services Company A [Member] Change in fair value of contingent consideration Change in estimated fair value Change in fair value of contingent consideration Change in fair value of contingent consideration Plan Name [Axis] Equity [Abstract] Entity Current Reporting Status Operating and financing lease liabilities, noncurrent Operating and Financing Lease Liabilities, Noncurrent Operating and financing lease liabilities, noncurrent. Operating expenses: Purchase price of common stock value Purchase price of common stock value. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common stock, shares authorized ROU operating and financing lease assets Right Of Use Operating and Financing Lease Assets Right of use operating and financing lease assets. Product and Service [Axis] Document Fiscal Period Focus Total minimum lease payments Finance Lease, Liability, to be Paid Pharma Services Company B [Member] Pharma Services Company B [Member] Accounting Standards Update 2023-09 [Member] ASU 2023-09 [Member] Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases Schedule of operating and finance lease balance sheet [TableTextBlock] Entity Shell Company Sale of stock, percentage of ownership sold. Sale Of Stock Percentage Of Ownership Sold Percentage of ownership sold Professional Fees, Legal, and Outside Services Professional fees, legal, and outside services. Professional fees, legal, and outside services Cash and cash equivalents Cash and cash equivalents Less: Less [Abstract] Less. Common stock, shares issued Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Cybersecurity Risk Board of Directors Oversight [Text Block] Contractual Value Business Combination, Contingent Consideration, Liability Contractual value. Statement [Table] Restricted cash Restricted cash, noncurrent Fair value grants Operating sublease, description Payments to Acquire Businesses, Gross Earnout payments Statement [Line Items] Business Combination [Domain] Revenue Recognition Merger Agreement [Member] Merger Agreement [Member] Machinery And Equipment Purchases, And Construction In Progress Included In Accounts Payable And Accrued Liabilities Machinery and equipment purchases, and construction in progress included in accounts payable and accrued liabilities. Machinery and equipment purchases, and construction in progress included in accounts payable and accrued liabilities Warrant [Member] Entity Filer Category Reclassifications General and Administrative Expenses Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Long-Lived Tangible Asset [Axis] Severance costs Severance obligations Finance Lease, Liability, to be Paid, Year Three 2027 2029 Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Share price Share price Subsequent Event [Line Items] Broadwood Capital LP [Member] Broadwood Capital LP [Member] Broadwood Capital LP [Member] Cybersecurity Risk Management Third Party Engaged [Flag] Operating and Financing Lease Right of Use assets Accumulated amortization Operating and financing lease right of use assets accumulated amortization. Accumulated amortization First Ten Calendar [Member] First Ten Calendar [Member] Finance Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 Patrick W. Smith [Member] Patrick W. Smith. Geographical [Domain] Inventory, Finished Goods, Gross Inventory finished goods Cash, Cash Equivalents and Restricted Cash NONCURRENT ASSETS NONCURRENT ASSETS Accounts receivable, allowance for credit loss Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Shares withheld related to net share settlement of stock-based awards Shares withheld related to net share settlement of stock-based awards Percentage of shares issued and outstanding Percentage Of Shares Issued And Outstanding Percentage of shares issued and outstanding. Summary of Significant Accounting Policies Property, Plant and Equipment [Line Items] Long-lived intangible assets, useful life Vesting [Domain] Stock option grant Number of awards outstanding, awards granted Disaggregation of Revenue [Table] Investment, Name [Axis] Operating and Financing Lease Liabilities, Current Operating and financing lease liabilities, current. Operating and financing lease liabilities, current Net loss attributable to common stockholders per share - basic Net (loss) income attributable to common stockholders per share - basic Net loss per share - basic Schedule of Disaggregation of Revenue Life Technologies Corporation [Member] Life Technologies Corporation [Member] Retirement Plan Foreign currency translation adjustments Foreign currency translation adjustment Number of options outstanding, beginning of period Number of options outstanding, end of period Stock options outstanding Beneficial ownership considered Beneficial ownership considered to sale shares under agreement. Beneficial ownership considered Finite-Lived Intangible Assets Acquired Intangible assets acquired value Total current liabilities Liabilities, Current Accounts receivable Increase (Decrease) in Accounts Receivable Adjustments to reconcile net loss to net cash used in operating activities: Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Achievement Of Market Capitalization Achievement of market capitalization. Achievement of market capitalization PIPE Purchase Agreement [Member] PIPE Purchase Agreement. Accounting Standards Update [Axis] Product Concentration Risk [Member] SHAREHOLDERS' EQUITY (DEFICIT) SHAREHOLDERS' DEFICIT Entity Small Business Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Total Accumulated deficit Earnout percentage on collections for sales Earnout percentage on collections for sales. Preferred Stock [Member] Number of options, forfeited/expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Sale of stock price per share Sale of stock price per share Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Exercises In Period Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award equity instruments other than option exercises in period weighted average grant date fair value. Weighted average exercise price, RSUs exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Aggregrate intrinsic value balance, options exercised Stock-Based Compensation Organization, Consolidation and Presentation of Financial Statements [Abstract] Office Lease Agreement [Member] Office Lease Agreement [Member] Travel and Entertainment Expense Travel and entertainment Laboratory Developed Test Services [Member] Laboratory Developed Test Services [Member] Lease Contractual Term [Axis] Lessee, Lease, Description [Line Items] Amendment Flag Product and Service [Domain] Loss Contingencies [Line Items] Purchase of warrant Warrant to purchase common stock Net Loss Per Common Share LIABILITIES AND SHAREHOLDERS' DEFICIT LIABILITIES AND SHAREHOLDERS' DEFICIT Entity Address, Postal Zip Code Net cash used in operating activities Net cash used in operating activities Equity compensation for bonus awards and consulting services Equity compensation for bonus awards and consulting services. Lease assets and liabilities Operating lease assets and liabilities Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Common Stock [Member] Pura Vida Investments LLC [Member] Pura Vida Investments LLC [Member] Pura Vida Investments LLC [Member] Cybersecurity Risk Role of Management [Text Block] Weighted average exercise price, awards granted Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated depreciation and amortization Operating and Financing Leases [Member] Operating and Financing Leases [Member] Business combination, contingent consideration, liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Entity Address, Address Line One Schedule of Assumptions Used to Calculate Fair Value of Stock Options Fair Value Hierarchy and NAV [Axis] Net loss per share (Note 2): Net loss per share Income Taxes Unobservable Measurement Input, Uncertainty, Description Unobservable measurement input, uncertainty, description Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Gains and Losses Sublease rent expenses. Rent receivable Sublease Rent Expenses Machinery and equipment ROU machinery and equipment Statement of Financial Position Location, Balance [Axis] Right-of-use assets, net ROU assets, net Less amounts representing interest Finance Lease, Liability, Undiscounted Excess Amount Beginning on or After January 1, 2025 and Ending on or Before June 20, 2025 [Member] Sublease Period Two [Member] Sublease period two. Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] AWM [Member] AWM [Member] AWM. Issuance of common stock upon exercise of pre-funded warrants Stock Issued During Period Upon Exercise Of Pre-Funded Warrants Stock issued during period upon exercise of pre-funded warrants. Document Type Intangible Assets Cash paid for income taxes Income Taxes Paid, Net, Total Income taxes paid, net of refunds received Gross profit Gross Profit Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Tenant improvement allowance Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Nashville Office and Facilities Leases [Member] Nashville office and facilities leases. Equity Method Investment Number Of Shares Held Equity method investment, number of shares held. Equity method investment, number of shares held Valuation Approach and Technique [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Subsequent Event Type [Domain] Total Chronix Acquisition [Member] Chronix Acquisition [Member] Par value Common Stock, Par or Stated Value Per Share Accounting Standards Update [Domain] Security deposit Deferred tax assets related to contingent consideration Business Combination, Recognized Asset Acquired, Deferred Tax Asset Tranche One [Member] Weighted average remaining contractual life Milestone 3 [Member] Milestone 3 [Member] Pharma Services [Member] Pharma Services [Member] Liabilities, Total [Member] Liabilities [Member] Laboratory Equipment [Member] Laboratory Equipment [Member] Laboratory Equipment [Member] Payment for Commitment Fee Payment for commitment fee. Payment for commitment fee Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Stock options exercised, shares Number of options outstanding, options exercised Number of options outstanding, options exercised Laboratory Services [Member] Laboratory Services [Member] Laboratory services. Segments, Geographical Areas [Abstract] Percentage of administrative fee paid on original cost of equipment Percentage of administrative fee paid on original cost of equipment. Accrued compensation Accrued compensation Value issued restricted Value issued restricted Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Arno [Member] Arno [Member] Underwritten Offering [Member] Underwritten Offering [Member] Document Quarterly Report Customer Relationships [Member] Offering price to Insiders Sale Of Stock Offering Price Per Share To Insiders Sale of stock offering price per share to insiders. Entity Address, State or Province Number of RSUs Outstanding, beginning of period Number of RSUs Outstanding, end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Fair value of options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value. Gross proceeds percentage Earnout percentage on collections for sale. Minimum requirement for each lease schedule amount Minimum Requirement for each Lease Schedule Amount Minimum requirement for each lease schedule amount. Investment, Name [Domain] Beginning on or After July 1, 2025 and Ending on or Before December 31, 2025 [Member] Sublease Period Three [Member] Sublease period three. Preferred stock, shares outstanding Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Research and Development Expenses Common stock reserved for future issuance Geographical [Axis] Segment Reporting Clinical Trial Expenses Segment reporting clinical trial expenses. Clinical trial and registry service fees Assets Held for Sale Accounts Receivable [Member] Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares withheld related to net share settlement of stock-based awards,Shares Shares withheld related to net share settlement of stock-based awards, shares Weighted average remaining recognition of period Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term. Obligated to pay expenses and taxes percentage Obligated to pay expenses and taxes percentage. Summary of Stock-based Compensation Expense Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Lease Line Amount Maximum International Equipment Lease line amount maximum lnternational equipment. Lease line amount maximum lnternational equipment Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Components of Deferred Tax Assets and Liabilities Schedule of Prior Period Revisions Schedule of Prior Period Revisions [Table Text Block] Schedule of Consolidated Revenues Generated by Unaffiliated Customers Equity Option [Member] Stock Options [Member] Subsequent Event [Member] Subsequent Event [Member] Marketable Equity Securities International Equipment, Sale and Leaseback [Member] International equipment, sale and leaseback. Property, Plant and Equipment [Abstract] Other noncurrent assets Other noncurrent assets Expected term [Member] Measurement Input, Expected Term [Member] Antidilutive Securities [Axis] Other Liability, Current, Related Party [Extensible Enumeration] Vested percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregrate intrinsic value, options vested and exected to vest Expense Included In Discontinued Operations [Member] Expense Included in Discontinued Operations [Member] Warrants expired Warrant expired. Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income [Member] Customer [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] February 2025 Offering [Member] February 2025 offering member. Lease, option to extend, description Lessee, Operating Lease, Option to Extend Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding Minimum [Member] Minimum [Member] Share price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, RSUs and PSUs granted CURRENT ASSETS CURRENT ASSETS Area of lab. Area of lab Accrued expenses and other current liabilities Accrued expenses and other current liabilities Warrants to purchase shares Warrants to purchase shares Amortization of intangible assets Intangible asset amortization expense Intangible asset amortization expense Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Right of Use Operating Lease Cost Expense Right of use operating lease cost expense. ROU operating lease cost expense, based on the capitalized lease cost Segment Reporting [Abstract] International Equipment [Member] International equipment. CURRENT LIABILITIES Beginning on or After January 1, 2027 and Ending on or Before October 31, 2027 [Member] Sublease Period Five [Member] Sublease period five. Operating Lease Rent to be Paid During Two Years Operating lease rent to be paid during two years. Operating lease rent to be paid during two years Related Party Transactions [Abstract] Balance, shares Balance, shares Shares, Outstanding Sublease income Accounts receivable, net of allowance for credit losses of $11 and $16, respectively Accounts receivable, net of allowance for credit losses of $2 and $11, respectively Accounts receivable Lease extension term Lessee, Operating Lease, Renewal Term DetermaCNI DetermaCNI [Member] DetermaCNI. Commitments and contingencies (Note 6) Commitments and contingencies (Note 6) Leases 2010 Plan and 2018 Incentive Plan Activity [Member] 2010 Plan and 2018 Incentive Plan Activity [Member] Weighted average exercise price, options outstanding, beginning of period Weighted average exercise price, exercisable, end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value General and Administrative Expense [Member] General and Administrative Expenses [Member] Total operating lease liabilities Present value of net minimum lease payments Gross accounts receivable Accounts Receivable, before Allowance for Credit Loss, Current Common stock, no par value Common stock no par value Inventories Inventory, Raw Materials and Supplies, Gross Inventory, Raw Materials and Supplies, Gross, Total Restricted Cash, Current Restricted cash, current Global Strategic Partnership Agreement Period Global strategic partnership agreement period Global strategic partnership agreement period Concentration Risk Benchmark [Axis] Royalty 1 [Member] Royalty 1 [Member] Current liabilities Lease liabilities, current Lessee, Lease, Description [Table] Weighted average discount rate, Financing lease Chronix Biomedical Inc [Member] Chronix Biomedical Inc [Member] NONCURRENT LIABILITIES NONCURRENT LIABILITIES Weighted average remaining recognition period RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation, Total Finance Lease, Right-of-Use Asset, Accumulated Amortization ROU accumulated amortization Interest expense Interest expense Interest expense Interest Income (Expense), Operating, Total Lease Contractual Term [Domain] Accrued interest and penalties Taxes Accrued Related To Net Share Settlement Of Stock-based Awards Taxes accrued related to net share settlement of stock-based awards Taxes accrued related to net share settlement of stock-based awards Taxes accrued related to net share settlement of stock-based awards Pharma Services Company E [Member] Pharma Services Company E [Member] Pharma services company E. Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Loss Contingencies [Table] Weighted average shares outstanding - basic Weighted average shares outstanding - basic Financing Leases [Member] Financing Leases Other Income and Expenses Other Income and Expenses [Policy Text Block] Other income and expenses. Scenario [Axis] Document Information [Line Items] Monte Carlo Valuation Technique [Member] Monte Carlo Valuation Technique [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregrate intrinsic value balance, options exercisable Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Income Tax Reconciliation Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Schedule of Future Minimum Lease Commitments for Operating and Financing Leases Schedule of future minimum lease commitments for operating and financing leases [Table Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Proceeds from private placement Net Proceeds from Issuance of Private Placement Net proceeds from issuance of private placement. Net proceeds from issuance of private placement Subsequent Events [Text Block] Subsequent Events Related Party Transactions Contingent consideration liabilities, current Business Combination, Contingent Consideration, Liability, Current Balance Balance Equity, Attributable to Parent Total shareholders' deficit Principles of Consolidation and Basis of Presentation Lessee, Operating Lease, Existence of Option to Extend [true false] Performance-based Restricted Stock Units [Member] Performance-based restricted stock units. Performance-based Restricted Stock Units (PSUs) [Member] Statement of Stockholders' Equity [Abstract] Fair Value Measurements, Business Combinations and Contingent Consideration Liabilities Business Combinations and Fair Value Measurements [Policy Text Block] Tranche Two [Member] Maximum percentage of annual lease expenses Maximum Percentage Of Annual Lease Expenses Maximum percentage of annual lease expenses. Cost of Revenues Valuation Approach and Technique [Domain] Customer One [Member] Customer One [Member] Use of Estimates Gain (Loss), Foreign Currency Transaction, before Tax Gain (Loss), Foreign Currency Transaction, before Tax, Total Gain (loss), foreign currency transaction Selling and Marketing Expense [Member] Machinery and equipment, net, and construction in progress Machinery and equipment net and construction in progress. Machinery and equipment, net, and construction in progress UNITED STATES United States [Member] Product Information [Line Items] SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES Measurement Input, Discount Rate [Member] Discount rate [Member] Measurement Input, Discount Rate [Member] Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Schedule of Unrecognized Tax Benefit Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, Other Segment Item, Amount Other segment items Plan Name [Domain] Entity [Domain] Equity interest Ownership percentage Equity method investment ownership percentage Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Beginning on Commencement Date and Ending on or Before December 31, 2024 [Member] Sublease Period One [Member] Sublease period one. Sale of common shares, net of financing costs Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Finance Lease, Liability, to be Paid, Year One 2027 Razor Genomics, Inc. [Member] Razor Genomics, Inc. [Member] 2018 Incentive Plan [Member] 2018 Incentive Plan [Member] Warrants issued and outstanding Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Related and Nonrelated Parties [Axis] Machinery and Equipment, Net, and Construction in Progress Property and Equipment At The Market Offering [Member] At The Market Offering [Member] At The Market Offering. Entity Address, City or Town Fair Value on the Merger Date Stock Repurchased During Period, Shares Warrants Repurchased Geographic Areas, Long-Lived Assets [Abstract] Long-lived assets by geographic area: Number of Reportable Segments Number of reportable segment Security Exchange Name Europe [Member] Intangible Assets, Net Counterparty Name [Axis] Personnel Related Expenses and Board Fees Personnel-related expenses and board fees. Personnel-related expenses and board fees Number of options, vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Concentration Risk Type [Domain] Germany Office and Facilities Leases [Member] Germany Office and Facilities Leases. Accrued royalties Accrued royalties Measurement Input Type [Domain] Antidilutive Securities, Name [Domain] Company D [Member] Company d. Inventories Inventory, Net Inventory, Net, Total Business combination, contingent consideration, liability, milestone payment Business Combination, Contingent Consideration, Liability, Milestone Payment Business combination, contingent consideration, liability, milestone payment. Co development agreementwith life technologies corporation [TextBlock] Co development agreementwith life technologies corporation [TextBlock] Collaborative Arrangement Cash paid for interest Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Mr Gutfreund [Member] Mr Gutfreund [Member] Statistical Measurement [Domain] Warrant exercise price, per share Warrant exercise price Total current assets Assets, Current Stock-based compensation expense Stock-based compensation Stock-based compensation Document Period End Date Percentage of shares outstanding Percentage Of Share Outstanding Percentage of share outstanding. Title and Position [Axis] Fair Value Hierarchy and NAV [Domain] Number of Options, Options Outstanding and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Redemption of Series A redeemable convertible preferred stock Value of redeemed shares Operating Lease Rent to be Paid Thereafter Operating lease rent to be paid thereafter. Operating lease rent to be paid thereafter Rentable area DetermaCNI, GraftAssureCore, GraftAssureIQ and GraftAssureDx [Member] DetermaCNI, GraftAssureCore, GraftAssureIQ and GraftAssureDx. DetermaCNI, GraftAssureCore, GraftAssureIQ and GraftAssureDx [Member] DetermaCNI [Member] Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) [Member] PIPE and RD Purchase Agreement [Member] PIPE and RD Purchase Agreement. Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] Pura Vida [Member] Pura Vida [Member] Pura Vida [Member] Class of Stock [Axis] Cybersecurity Risk Management, Strategy, and Governance [Line Items] Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] MPC Holdings LLC [Member] MPC Holdings LLC [Member] TOTAL LIABILITIES Liabilities Cumulative change in accounting principle (Note 2) Cumulative change in accounting principle. Share-Based Compensation Arrangement by Share-Based Payment Award, Description Share based payment award description Milestone 2 [Member] Milestone 2 [Member] Investments in Privately Held Companies Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Company C [Member] Company c. Restricted cash Restricted Cash Restricted Cash, Total Unobservable measurement input, weighted average cost of capital Weighted Average Cost of Capital Weighted Average Cost of Capital Advertising expense Financing lease amortization expense Finance Lease, Right-of-Use Asset, Amortization Weighted average shares outstanding - diluted Weighted average shares outstanding - diluted Entity File Number Marketing and Advertising Expense Marketing and advertising Accounting Standards Update 2023-07 [Member] ASU 2023-07 [Member] Cover [Abstract] Measurement Input Type [Axis] February 2026 Offering [Member] February 2026 offering member. Accounts payable and accrued liabilities Accounts payable and accrued liabilities Segment Reporting Information, Profit (Loss) [Abstract] Reconciliation of segment profit and loss: Beginning on or After January 1, 2026 and Ending on or Before December 31, 2026 [Member] Sublease Period Four [Member] Sublease period four. Prepaid expenses and other current assets Prepaid expenses and other current assets Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Nonvested RSUs, Number Outstanding, RSUs forfeited MPEEM Valuation Approach [Member] MPEEM Valuation Approach [Member] Schedule of Contingent Consideration, Measured at Fair Value Schedule of contingent consideration measured at fair value [Table Text Block] Revenue Benchmark [Member] Scenario [Domain] Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Unrealized foreign currency losses Sale of Stock [Domain] Segment Reporting Segment Reporting Disclosure [Text Block] General and Administrative Expense, Total General and administrative General and administrative Machinery, equipment and leasehold improvements Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Customer Two [Member] Customer Two [Member] Contingent consideration liabilities, noncurrent Balance Balance Subsequent Event [Table] Geographic Areas, Revenues from External Customers [Abstract] Revenues by geographic area: Collaborative Arrangements Segments Segments [Policy Text Block] DetermaIO [Member] DetermaI O [Member] Sale of common shares, net of financing costs, shares Issuance of shares Financing costs to issue common shares in accounts payable and accrued liabilities Financing Costs To Issue Common Shares Included In Accounts Payable And Accrued Liabilities Financing costs to issue common shares included in accounts payable and accrued liabilities. Weighted average exercise price, options vested and exected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Nature of Operation, Product Information, Concentration of Risk [Table] Estimated useful life of plant and equipment Recent Accounting Pronouncements Milestone 1 [Member] Milestone 1 [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Oncocyte Corporation [Member] Oncocyte corporation. Oncocyte Corporation Option vesting period Monthly Rent [Member] Monthly Rent [Member] Bio Rad Laboratories Inc [Member] Bio Rad Laboratories Inc [Member] Bio Rad Laboratories Inc [Member] Unrecognized stock based compensation expense for RSUs Payout percentage Business Combination, Contingent Consideration, Liability, Payout Percentage Business combination, contingent consideration, liability, payout percentage Cost of Revenue Net of Depreciation Expense Cost of revenue net of depreciation expense. Cost of revenues, as adjusted Lease term Common stock, shares outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Right-of-use lease liabilities, current Lease liabilities, current Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Depreciation, Depletion and Amortization Depreciation and amortization expenses Depreciation, Depletion and Amortization, Total James [Member] James. Cybersecurity Risk Management Processes Integrated [Flag] Document Transition Report Accretion of Series A convertible preferred stock to redemption value Accretion of Series A redeemable convertible preferred stock Accretion of Series A convertible preferred stock to redemption value. Total operating expenses Operating Expenses Research and development expenses Research and Development Expense, Total Research and development Research and development Cost of revenues Cost of Revenue, Total Cost of revenues Valuation Technique, Discounted Cash Flow [Member] Kitted Products [Member] Kitted products. Kitted Products [Member] Statement of Cash Flows [Abstract] Sale of common shares under at-the-market transactions, net of financing costs Preferred stock offering value in tranche Common stock shares issued Summary of Stock Option Activity Series A Redeemable Convertible Preferred Stock and Shareholders' Deficit Shareholders' (Deficit) Equity Customer Four [Member] Customer four. Stock-based compensation expense for RSUs Finite-Lived Intangible Assets [Line Items] Financing Lease Arrangement for Equipment [Member] Financing lease arrangement for equipment. Cybersecurity Risk Management Processes Integrated [Text Block] Net loss Net loss Aggregrate intrinsic value balance Aggregrate intrinsic value balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Inventory write down Inventory Write-down Inventories Increase (Decrease) in Inventories Increase (Decrease) in Inventories, Total Facilities and Insurance Facilities and Insurance. Facilities and insurance Total lease cost Weighted average remaining life Insight Genetics Inc [Member] Insight Genetics Inc [Member] Collaborative agreement, term period Collaborative Agreement, Term Period Collaborative agreement, term period. Aggregate Payments in Financing Lease Arrangement Aggregate payments in financing lease arrangement. Aggregate payments in financing lease arrangement Dividend yield Operating cash flows from operating leases ASSETS ASSETS Risk-free interest rates Risk-free interest rate Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Document Fiscal Year Focus Asia Pacific [Member] Pharma Services Other [Member] Pharma Services Other [Member] Pharma services other. Vesting of bonus awards Stock issued during period value vesting of bonus awards. Concentration Risk Benchmark [Domain] Deemed dividend on Series A redeemable convertible preferred stock Deemed dividend on Series A redeemable convertible preferred stock. CASH FLOWS FROM INVESTING ACTIVITIES: Accounts payable Accounts payable Research and Development Expense [Member] Research and Development Expense [Member] Warrant Excercised Warrant excercised. Warrant exercised Property, Plant and Equipment Before Construction in Progress Property, plant and equipment before construction in progress. Property, plant and equipment before construction in progress Lease assets obtained in exchange for lease liabilities Customer Three [Member] Customer three. Segment Income (Loss) from Operations Segment income (loss) from operations. Segment loss Proceeds from Stock Options Exercised Proceeds from exercise of stock options Commitments and Contingencies Disclosure [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Reduction in Letter Of Credit Amount Reduction in letter of credit amount. Reduction in letter of credit amount Broadwood Partners LP [Member] Broadwood Partners LP [Member] Broadwood Partners LP [Member] Share-Based Payment Arrangement [Abstract] Unrecognized stock based compensation expense Underwriters [Member] Underwriters [Member] Repayment of financing lease obligations Repayment of financing lease obligations. RepaymentOfFinancingLeaseObligations Sale of Stock [Axis] Percentage of revenues Percentage of consolidated revenues Concentration risk percentage Net cash used in investing activities Net cash provided by (used in) investing activities Private Placement [Member] Private Placement [Member] Unobservable measurement input, discount period on expected life of patent Discount Period On Expected Life Of Patent Discount Period On Expected Life Of Patent Weighted average remaining lease term, Financing lease Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Weighted average exercise price, forfeited/expired Weighted average exercise price, options outstanding, RSUs forfeited Weighted Average Grant Date Fair Value, RSUs forfeited Related and Nonrelated Parties [Domain] Purchases. Purchases [Member] Income Tax Disclosure [Text Block] Income Taxes Collaborative Arrangement and Arrangement Other than Collaborative [Table] Lease Agreement [Member] Lease Agreement [Member] Redemption of SeriesA redeemable convertible preferred stock, shares Number of stock redeem, shares Sale Of Stock Number Of Shares Sold Sale of stock, number of shares sold. Number of shares sold Accounts Payable [Member] Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 Document Information [Table] Office Sublease Agreement [Member] Office Sublease Agreement [Member] Office sublease agreement. Right-of-use and financing lease assets, net Right-of-use operating and financing lease assets, net ROU machinery and equipment, net Legal Entity [Axis] Changes in operating assets and liabilities: Schedule of Right-of-use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress Weghted average exercise price, beginning of period Number of options outstanding, ending of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Income Tax Disclosure [Abstract] Business Combinations and Contingent Consideration Liabilities Balance at end of year Unrecognized tax benefits Unrecognized tax benefits Balance at the beginning of the year Share issued, value Shares issued for consultant services United Kingdom [Member] UNITED KINGDOM Statement of Income Location, Balance [Axis] Accrued contingent consideration liability payments due Accrued Contingent Consideration Liability Payments Due Accrued contingent consideration liability payments due. Trading Symbol Intangible Asset, Finite-Lived [Table] Property and Equipment Property and Equipment, Net Related Party Transaction [Table] Related Party Transaction [Table] Subsequent Event Type [Axis] CASH FLOWS FROM FINANCING ACTIVITIES: Lessee, Finance Lease, Term of Contract Financing lease term Expected life (in years) Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Less amounts representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Selling and Marketing Expense, Total Sales and marketing Sales and marketing Unterberg Legacy Capital, LLC [Member] Unterberg Legacy Capital, LLC. Equity Components [Axis] Weighted average remaining contractual life vested and expected to vest Line of credit Total other income, net Nonoperating Income (Expense) Equity Component [Domain] Chronix Milestone [Member] Chronix Milestone [Member] Operating and Financing Lease Right Of Use Assets Operating and financing lease right of use assets. Right-of-use operating and financing lease assets, net Total, net (Note 6) Goodwill and Intangible Assets Disclosure [Abstract] Business Combination [Axis] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Shares issued upon vesting of RSU, shares Machinery and Equipment [Member] Stock-based compensation Company B [Member] Company b. Customer [Axis] Option maximum contractual term Executive Officers [Member] Executive Officers [Member] Commitment Fee Commitment fee. Commitment fee Depreciation expense Depreciation and amortization expense Collaborative Arrangements Collaborative Arrangement, Accounting Policy [Policy Text Block] Financing lease monthly rental factor Financing Lease Monthly Rental Factor Financing lease monthly rental factor. Maximum [Member] Maximum [Member] Statistical Measurement [Axis] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price, options exercised Balance at January 1, 2023, as adjusted Total Shareholders equity Adjusted stockholders' equity. Common stock, no par value, 230,000 shares authorized; 28,683 and 17,453 shares issued and outstanding at December 31, 2025 and 2024, respectively Common stock, no par value, 230,000 shares authorized; 32,623 and 28,683 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Finance lease payments Financing cash flows from financing leases Financing lease payments to third-party Lease expiration month and year Lease Expiration Month And Year Lease expiration month and year. Schedule of Supplemental Cash Flow Information Related to Operating and Financing Lease Schedule of operating and finance lease cashflow [Table Text Block] Equipment [Member] Schutz [Member] Schutz. Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Impairment of Long-Lived Assets Offering price to investors Sale Of Stock Offering Price Per Share To Investors Sale of stock offering price per share to investors. Warant Unexercised Warant unexercised. Warrant unexercised Schedule of Intangible Assets Future Amortization Expense Volatility Expected volatility Preferred stock, shares authorized Preferred stock, shares authorized Royalty Expense Royalty expense Finite-Lived Intangible Assets by Major Class [Axis] Related party transaction, description Taxes paid related to net share settlement of stock-based awards Payment, Tax Withholding, Share-Based Payment Arrangement Management probability estimate [Member] Measurement Input, Management Probability Estimate [Member] Measurement input, management probability estimate. Related Party Transaction [Line Items] Business Combination [Table] Unobservable measurement input, valuation approach yielded fair value Valuation Approach Yielded Fair Value Valuation Approach Yielded Fair Value Financing Lease Additional Monthly Rental Factor Financing lease additional monthly rental factor. Financing lease additional monthly rental factor Entity Registrant Name Customer Concentration Risk [Member] Schedule of Fair Value of Contingent Consideration Liability Other income, net Other Nonoperating Income (Expense), Total Other income, net Lessee Finance Lease Additional Extended Term Lessee finance lease additional extended term. Lessee finance lease additional extended term Subsequent Events [Abstract] Accounts Payable and Accrued Liabilities, Current Accounts Payable and Accrued Liabilities, Current, Total Accounts payable and accruals due Cybersecurity Risk Management Positions or Committees Responsible [Flag] Business combination, contingent consideration, liability, related patent expiration range term Business Combination, Contingent Consideration, Liability, Related Patent Expiration Range Term Business combination, contingent consideration, liability, related patent expiration range term. Income Tax Expense (Benefit) Provision or benefit for income taxes Income taxes Effective tax rates, Amount Stock Repurchased During Period, Value Warrants from Investors Assets held for sale Asset, Held-for-Sale, Not Part of Disposal Group, Current, Total Proceeds from sale of common shares Proceeds from issuance of common stock Gross proceeds from issuance of common stock Business Combination, Contingent Consideration, Type [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Sale and Leaseback [Member] Sale and leaseback. Entity Common Stock, Shares Outstanding Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Razor Stock Purchase Agreement [Member] Razor Stock Purchase Agreement [Member] Accumulated other comprehensive income Accumulated other comprehensive income Payments to Acquire Property, Plant, and Equipment, Total Machinery and equipment purchases, and construction in progress Acquired laboratory equipment Number of shares granted Nonvested RSUs, Number Outstanding, RSUs and PSUs granted Company A [Member] Company a. TOTAL ASSETS Assets Inventories Inventory, Policy [Policy Text Block] Property, Plant and Equipment [Table] Weighted average remaining contractual life exerciseable Income Statement [Abstract] 2010 Stock Option Plan [Member] 2010 Stock Option Plan [Member] Operating cash flows from financing leases Preferred stock, no par value Preferred stock, no par value Number of sale of shares Sale of stock, shares Issuance of common stock shares Pharma Services Company D [Member] Pharma Services Company D [Member] Sale of common shares under at-the-market transactions, net of financing costs, shares Number of shares issued Chronix Merger [Member] Chronix Merger [Member] Number of shares vested Nonvested RSUs, RSUs and PSUs vested New Equipment [Member] New Equipment. Fair value Fair value of contingent consideration. Net loss attributable to common stockholders per share - diluted Net (loss) income attributable to common stockholders per share - diluted Net loss per share - diluted Machinery Equipment and Leasehold Improvements [Member] Machinery, equipment and leasehold improvements. Machinery, Equipment and Leasehold Improvements [Member] Dragon Scientific LLC [Member] Dragon Scientific LLC [Member] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Single Reportable Segment Profit or Loss Information Title and Position [Domain] City Area Code Payments for rent Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Incentive plan expiration date Noncurrent liabilities Lease liabilities, noncurrent Long-Lived Intangible Assets Schedule of Intangible Assets, Net Business Combination [Line Items] Counterparty Name [Domain] Accounting Principles Accounting Principles [Policy Text Block] Aggregate fair value of RSUs vested Weighted average remaining lease term, Operating lease Segment Reporting Information [Line Items] Shares issued restricted Shares issued restricted Lease expiration date Lease Expiration Date Cost Of Revenues [Member] Cost of Revenues [Member] Lease, Cost Lease, Cost, Total Lease cost Sales and Marketing Expenses Sale sAnd Marketing Expenses [Policy Text Block] Prior Period Revisions Prior Period Revisions Policy [Text Block] Property, Plant and Equipment, Net Total, net Shares issued upon vesting of RSUs Impairment losses Impairment losses Impairment of intangible assets Impairment losses CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash and cash equivalents with restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING Loss from operations Operating Income (Loss) Net operating income Loss from operations Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations Schedule of Revenues and Long-lived Assets by Geographic Area Accumulated Deficit [Member] Retained Earnings [Member] Business Combination, Contingent Consideration, Type [Domain] Stock-based compensation expense for the period Stock-based compensation Unrecognized stock-based compensation expense Financing costs to issue common shares Payments of Stock Issuance Costs Offering expenses Placement agent fees and offering expenses Chronix Equity [Member] Chronix Equity [Member] Weighted average discount rate, Operating lease Right-of-use lease liabilities, noncurrent Lease liabilities, noncurrent Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Royalty 2 [Member] Royalty 2 [Member] Accounting for Warrants Accounting For Warrants [Policy Text Block] Other (expenses) income: Other (expenses) income: Pharma Services Company C [Member] Pharma Services Company C [Member] Outside of the United States Non-US [Member] Schedule of Antidilutive Potential Common Shares Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Interactive Data Current Laboratory Supplies and Expenses Laboratory supplies and expenses. Laboratory supplies and expenses Statement of Income Location, Balance [Domain] Laboratory related costs Laboratory related expenses Lease Line Amount Maximum Sale and Leaseback Lease line amount maximum sale and leaseback. Lease line amount maximum sale and leaseback CASH FLOWS FROM OPERATING ACTIVITIES: Adjusted balance, shares Adjusted shares outstanding. Shares issued for consultant services, shares Schedule of Concentration of Risk Entity Tax Identification Number Investor Relations Consulting Service Arrangement [Member] Investor relations consulting service arrangement. Share Price Market price Organization and Description of the Business Construction in progress Local Phone Number Weighted average exercise price, RSUs exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award equity instruments other than options exercises in period weighted average grant date fair value. Related Party Transaction [Domain] Due to related party (Note 9) Other Liabilities, Current Finance Lease, Liability, to be Paid, Year Two 2028 Maximum beneficial ownership considered Maximum beneficial ownership considered to sale shares under agreement. Long-Lived Assets Long-lived tangible asset Accounting Policies [Abstract] Specimen Collection Agreement [Member] Specimen Collection Agreement [Member] Specimen collection agreement. Disaggregation of Revenue [Line Items] Interest rate on lease agreement Refers to annual interest rate on capital lease agreement. Net revenue Revenues by type Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Class of Stock [Domain] Number of shares available for grant Weighted average remaining recognition period Stock, Class of Stock [Table] Entity Emerging Growth Company Series A Redeemable Convertible Preferred Stock [Member] Series A Redeemable Convertible Preferred Stock [Member] Schedule of Revenue from External Customers, Consolidated Revenue by Geographical Areas [Table Text Block] Schedule of Revenue from External Customers, Consolidated Revenue by Geographical Areas. Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations Area of land Chief Executive Officer and Chief Financial Officer. Chief Executive Officer and Chief Financial Officer [Member]